Oxford Global: NextGen Omics-US

  • -

NextGen Omics US: In-Person

Program Dates: March 29-30, 2022

Booth #4 | Hyatt Regency, Boston, MA

+ Digital Day: 31 March 2022 | Online

Event Overview

Delivering therapeutic innovation, applications and technologies in NGS, Single Cell Analysis and Genome Editing

Bringing together leading omics experts from around the world and comprised of three outstanding programmes, delegates can expect to benefit from critical discussions in the future of Next Generation Sequencing, Multi-omic Single Cell Analysis (including Spatial Transcriptomics) and Genome editing in Drug Discovery and Therapeutic Development. Following this is a dedicated Digital Day delivered through our online event platform.

NanoString Presentations

NanoString Presentation

29 March | 11:10 – 11:40 AM ET, Conference Room 1

Highest Plex, True Single-Cell Spatial Multiomics Solution: CosMx SMI

CosMxTM SMI revolutionizes single-cell and spatial biology research with:
• Highest plex (up to 1000 targets) RNA and protein expression analysis
• Tunable workflow: high-plex to high-throughput
• Formalin-Fixed Paraffin-Embedded (FFPE) compatibility

Speaker(s): Vikram Devgan, Ph.D., MBA., Senior Director of Spatial Genomics Business Unit, NanoString

Nanostring Panel Discussion

29 March | 12:05 – 12:30 PM ET, Conference Room 3

Overcoming Biomarker Discovery Challenges Using GeoMx, the Highest-Plex Spatial Omics Toolkit

• Use cases in drug development
• Enabling successful implementation of GeoMx in biomarker discovery
• Advancing biomarkers in clinical development through integration of spatial multi-cellular and spatial single-cell data

Moderator: Espy Anguiano, PhD, Scientific Market Development Director -BioPharma, NanoString


Benjamin Chen, MD, PhD, Scientific Director of Translational Pathology, Bristol Myers Squibb

Vikram Devgan, Ph.D., MBA., Senior Director of Spatial Genomics Business Unit, NanoString

Julien Tessier, PhD, Scientist, Precision Oncology, Genomics, Sanofi Pharma